HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship between metabolic phenotype of N-acetylation and bladder cancer.

AbstractOBJECTIVE:
To study the relationship between metabolic phenotype of acetylation and bladder cancer.
METHODS:
Totally 203 healthy volunteers and 67 patients with bladder cancer were investigated with caffeine as a metabolic probe. Urine samples were collected in 2-6 hours after a cup of 140 mg coffee was taken, and the caffeine metabolites, 5-acetylamino-6-formylamino-1-methyluracil (AFMU) and 1-methylxanthine (1X) were analyzed by high performance liquid chromatography (HPLC). The frequency histogram and probit plot were constructed to select the critical value which was used to assess slow and fast acetylation status both in healthy volunteers and patients with bladder cancer.
RESULTS:
The peak height ratios of AFMU and 1X (AFMU/1X) were from 0.06 to 6.50 for healthy volunteers and 0.10 to 6.31 for patients with bladder cancer, both with the critical value of 1.10. Of 203 healthy volunteers involved in this study, 26.3% were slow acetylacors, as compared to 46.3% with slow acetylacors in patients with bladder cancer. The odds ratio is 2.376, and the gene frequency for healthy volunteers and patients with urinary bladder cancer were 0.5218 and 0.6804, respectively.
CONCLUSIONS:
N-acetylation status in the Chinese population is polymorphic and completely concordant with that determined with other metabolic probes. Slow acetylators are significantly associated with bladder cancer.
AuthorsX Cui, R Guo, Z Xu, B Wang, C Li
JournalChinese medical journal (Chin Med J (Engl)) Vol. 113 Issue 4 Pg. 303-5 (Apr 2000) ISSN: 0366-6999 [Print] China
PMID11775223 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Xanthines
  • Caffeine
  • Uracil
  • 1-methylxanthine
  • 5-acetylamino-6-formylamino-3-methyluracil
Topics
  • Acetylation
  • Adult
  • Caffeine (metabolism)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • Uracil (analogs & derivatives, metabolism)
  • Urinary Bladder Neoplasms (etiology, metabolism)
  • Xanthines (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: